Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

PRS REIT hikes Q2 dividend, continues to seek suitor

(Sharecast News) - The PRS REIT declared an increased interim quarterly dividend of 1.1p per share for the second quarter of its financial year on Tuesday, up from 1p in the same period last year. It said the increase reflected continued rental and earnings growth, with dividends declared for the first half of the financial year now totaling 2.1p per share, fully covered by EPRA earnings.

The FTSE 250 real estate investment trust said the second-quarter dividend, which would be paid entirely as a property income distribution, was scheduled for payment on 7 March to shareholders on the register as of 21 February.

It also updated the market on its ongoing strategic review and formal sale process.

PRS said it had received several non-binding proposals for the acquisition of the company, most of which offered a premium to the current share price of 109.2p, but remained below the latest net asset value of 133.2p per share as of 30 June.

A select group of bidders would now be invited to proceed with confirmatory due diligence, which was expected to conclude by the end of the first quarter.

The board emphasised that there was no certainty an offer would be made, or on what terms.

It said it was continuing to explore all options to maximise shareholder value.

The Takeover Panel had granted a dispensation from certain disclosure requirements, allowing interested parties to remain anonymous while participating in the formal sale process without being subject to a 28-day deadline to make an offer.

At 0831 GMT, shares in the PRS REIT were up 2.35% at 111.76p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.